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ABSTRACT 
Evaluating the Effectiveness of Three Utah Wastewater Treatment Facilities in 
Removing Pharmaceuticals and Personal Care Products  
by 
Oksana Roth, Master of Science 
Utah State University, 2012 
Major Professor: Dr. William Doucette 
Department: Civil and Environmental Engineering  
 Occurrence and removal of ten pharmaceuticals and personal care products 
(PPCPs) in three wastewater treatment plants (WWTPs) in the State of Utah were 
evaluated. The selected treatment technologies, represented by Brigham, Hyrum, and 
Spanish Fork WWTPs, were oxidation ditches, membrane bioreactors, and trickling 
filters. Influent, effluent, and biosolids samples were collected in May, July, and August 
of 2011. The highest influent concentrations were measured for caffeine (3.9 – 15.4 
µg/L) and acetaminophen (7.4 – 71.5 µg/L). Sulfamethoxazole, tris(2-chloroethyl) 
phosphate, and carbamazepine were measured in the effluent of all three WWTPs. 
Removal efficiencies calculated from differences between influent and effluent 
concentrations were caffeine (>80%), acetaminophen (>99%), and sulfamethoxazole 
(>60%). Tris(2-chloroethyl) phosphate, carbamazepine, and bis(2-ethylhexyl) phthalate 
were not consistently found above the method limits of quantitation (LOQs). The fate of 
each compound, predicted based on biodegradability data and log Kow values, matched 
the observed data. The effluent concentrations of the measured PPCPs were below the 
levels of concern suggested by available toxicity data.                                      (75 pages) 
	  	  	   	  
iv 
PUBLIC ABSTRACT  
Evaluating the Effectiveness of Three Utah Wastewater Treatment Facilities in 
Removing Pharmaceuticals and Personal Care Products  
 The occurrence of Pharmaceuticals and Personal Care Products (PPCPs) in 
surface waters has become a growing concern within the last decade although the first 
mention of human PPCPs in the environment goes back to late 1970s. Pharmaceuticals 
include prescription drugs, over-the-counter medications, and veterinary drugs. Personal 
care products include products such as lotions, fragrances, and soaps. In addition to 
traditional personal care products, the term PPCPs has been adopted to represent a 
wide variety of chemicals used in consumer products including plasticizers and fire 
retardants. Wastewater effluents are thought to be the main source of PPCPs in surface 
waters since most pharmaceuticals and personal care products eventually are disposed 
of, directly or indirectly, into domestic sewage systems that are not specifically designed 
to treat them.   
 This thesis research examined the occurrence and removal of ten PPCPs in 
three Utah wastewater treatment plants (WWTPs) in the State of Utah. The ten PPCPs 
(caffeine, acetaminophen, sulfamethoxazole, tris(2-chloroethyl) phosphate, 
carbamazepine, estrone, progesterone, gemfibrozil, 4-n-nonylphenol, and bis(2-
ethylhexyl) phthalate) were selected for this study based on their chemical properties, 
environmental concern due to their widespread use, frequent detection in natural water, 
wastewater, and biosolids, and potential risk to the environmental and human health. 
The selected treatment technologies, represented by Brigham, Hyrum, and Spanish Fork 
WWTPs, were oxidation ditches, membrane bioreactors, and trickling filters. Influent, 
effluent and biosolids samples were collected in May, July, and August of 2011. The 
highest influent concentrations were measured for caffeine (3.9 – 15.4 µg/L) and 
acetaminophen (7.4 – 71.5 µg/L). Sulfamethoxazole, tris(2-chloroethyl) phosphate, and 
carbamazepine were measured in the effluent of all three WWTPs. Removal efficiencies 
calculated from differences between influent and effluent concentrations were caffeine 
(>80%), acetaminophen (>99%), and sulfamethoxazole (>60%). Tris(2-chloroethyl) 
phosphate, carbamazepine, and bis(2-ethylhexyl) phthalate were not consistently found 
above the method limits of quantitation (LOQs). The effluent concentrations of the 
measured PPCPs were below the levels of concern suggested by available toxicity data.   
 
Oksana Roth  	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INTRODUCTION 
Background 
The occurrence of Pharmaceuticals and Personal Care Products (PPCPs) in 
surface waters has become a growing concern within the last decade  (Kolpin et al. 
2002; U.S. EPA 2010a) although the first mention of human PPCPs in the environment 
goes back to late 1970s (Garrison et al. 1976). Pharmaceuticals include prescription 
drugs, over-the-counter medications, and veterinary drugs. Personal care products 
include products such as lotions, fragrances, and soaps (Daughton and Ternes 1999, 
U.S. EPA 2011a). In addition to traditional personal care products, the term PPCPs has 
been adopted to represent a wide variety of chemicals used in consumer products 
including plasticizers and fire retardants. Wastewater effluents are thought to be the 
main source of PPCPs in surface waters (Jones et al. 2005; Oulton et al. 2010) since 
most pharmaceuticals and personal care products eventually are disposed of, directly or 
indirectly, into domestic sewage systems that are not specifically designed to treat them 
(Jones et al. 2005; Shon et al. 2006; U.S. EPA 2009). For example, only 30% – 50% of 
most pharmaceuticals ingested by humans are metabolized. The remaining portion is 
excreted and eventually flows into wastewater treatment plants (WWTPs) or septic 
systems. Insect repellants and other personal care products applied to skin are often 
washed off and introduced into WWTPs.  
Surface waters containing PPCPs are a source of drinking water for many 
communities. A study by U.S. Geological Survey and University of North Carolina found 
low concentrations (ng/L) of antibiotic residue in drinking water obtained from surface 
water sources under the influence of upstream WWTPs  (Weinberg et al. 2004). Trace 
concentrations (ng/L) of 41 PPCPs were detected at the intake of a drinking water 
treatment plant in Spain (Boleda et al. 2011). Negative impacts on aquatic and wild life 
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as a result of exposure to PPCPs have been documented (Jobling et al. 1998; U.S. EPA 
2010a; Washington State Department of Ecology 2010).  
PPCPs not biologically degraded within the WWTP can sorb to the biosolids. 
Biosolids, “defined as solid, semi-solid, or liquid untreated residue generated during the 
treatment of domestic sewage in a treatment facility” (U.S. EPA 2004), are often 
disposed of through land application. Approximately 7 million tons of dry biosolids are 
produced in the U.S. annually (Washington State Department of Ecology 2010). 
According to the U.S. EPA, more than 60% of sludge produced as a result of sewage 
treatment is land applied (U.S. EPA 2011b). There is a concern that biosolids containing 
PPCPs may potentially become a source of contamination when land applied.  Kinney et 
al. (2008) detected PPCPs in earthworms collected from sites amended with biosolids 
from a municipal WWTP, suggesting that PPCPs present in biosolids can be transferred 
to earthworms. Therefore, in order to determine the extent to which PPCPs are treated 
by various wastewater treatment technologies, the concentrations of these compounds 
should be measured in wastewater effluent and biosolids.  
Wastewater Treatment Plants in the State of Utah 
 The selected wastewater treatment technologies are representative of the most 
common types of WWTPs in the State of Utah (Table 1). Out of 28 WWTPs in Utah, 
excluding lagoons and septic systems, nine are oxidation ditches (OD), thirteen are 
trickling filters (TF), two plants practice a combination of two treatment technologies, OD 
and TF, and four plants use membrane bioreactors (MBR) (Mark Schmitz, 
Environmental Scientist, UT DEQ, personal communication, May 17, 2011). There are 
24 discharging and 82 non-discharging lagoons in the State of Utah (Mark Schmitz, 
Environmental Scientist, UT DEQ, personal communication, August 15, 2011). Lagoons 
were not considered for the proposed research due to the fact that biosolids produced by 
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Table 1. WWTPs and treatment technologies 
	  
lagoon treatment systems are not disposed of by land application. Table 1 provides a 
summary of the treatment technologies in selected WWTPs, average flow rates recorded 
in 2011, and populations.  
Brigham City Wastewater Treatment Facility 
Brigham City is situated on the west side of the Wellsville Mountains in Box Elder 
County, UT. The total population of Brigham City is 17,411 (U.S. Census Bureau 2000). 
Of this population 2,115 people (12%) are 65 years of age and older. The treatment 
facility operates a “nitrifying extended aeration process using oxidation ditches with 
surface aeration” (CH2MHILL 2010a). Reported average flow rate is 3.2 mgd.  The 
facility’s headworks, clarifier, disinfection, and dewatering systems were updated in 2010 
to meet projected 40% flow increase due to the operation of a new Proctor and Gamble 
facility in Brigham City, UT. Ultra-violet radiation is used to disinfect secondary effluent 
prior to aeration and discharge into the Old Box Elder Creek. In 2010 Brigham City 
WWTP produced 370 metric tons of sludge; it was composted and sold to the public as 
Class A compost with an approximate percent solids content of 82±4%  (Rich Mickelsen, 
Brigham City, personal communication, June 14, 2011). 
Hyrum City Wastewater Treatment Facility 
Hyrum City is located in Cache County, UT with a total population of 6,316; this 
includes 329 people (5%) over the age of 65 (U.S. Census Bureau 2000). The average 
inflow to the plant is approximately 1.0 mgd. The influent wastewater is treated with an 
Brigham City 3.2 Oxidation ditches UV 17,411
Hyrum City 1.0 Anoxic/aerobic activated sludge/MBR UV 6,316
Spanish Fork 5.0 Trickling filters and activated sludge Chlorine 20,246
Disinfection 
type
Total 
populationWWTP
Average flow rate 
(mgd) Treatment type
	  	  	   	  
4 
anoxic and aerobic activated sludge process prior to the membrane bioreactors. Alum is 
added to influent wastewater for phosphorus treatment. Approximately 190 metric tons 
of Class B solids (88% solid) are annually applied to 160 acres of city-owned land. After 
UV disinfection the secondary effluent is discharged to the Spring Creek (CH2MHILL 
2010b). In 2012 the Hyrum WWTP will start to recycle treated effluent for secondary 
irrigation.  
Spanish Fork Wastewater Treatment Facility 
Spanish Fork is a city in Utah County, UT. In the 2000 census, the population 
was 20,246 including 1,280 people (6%) of 65 years of age and older (U.S. Census 
Bureau 2000). The facility is designed for 6 mgd flow with an average flow of 5 mgd and 
uses a combination of two treatment processes: a trickling filter process and an activated 
sludge process with STM-aerators (CH2MHILL 2010c; Dennis Sorensen, Spanish Fork, 
personal communication, October 20, 2010). Discharge from three industries comprises 
17% of the total flow in the Spanish Fork WWTP (Dennis Sorensen, Spanish Fork, 
personal communication, April 17, 2012). After preliminary treatment in the primary 
clarifiers, one-third of the flow undergoes the trickling filter process and the rest goes to 
an activated sludge process. Five hundred metric tons of Class B biosolids are produced 
at the facility each year and applied to two farms west of Spanish Fork. The solids 
content is on average 24% solids (Dennis Sorensen, Spanish Fork, personal 
communication, June 5, 2011). Following treatment in a chlorine contact chamber, the 
liquid effluent is discharged to a drainage ditch, formally known as Dry Creek. 
Project Objectives 
The main objective of this thesis research was to investigate the effectiveness of 
three Utah WWTPs, using three different treatment technologies in removing ten PPCPs 
that were selected based on their wide range of chemical properties and reports of being 
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found in WWTP effluent and biosolids. Removal effectiveness was evaluated by 
measuring the concentrations of these PPCPs in samples of the wastewater influent, 
effluent, and biosolids collected in May, July, and August of 2011. The wastewater 
treatment technologies used by the three WWTPs are oxidation ditches, trickling filters, 
and membrane bioreactors (MBR) represented by Brigham City, Spanish Fork, and 
Hyrum City, Utah, respectively. The secondary objective of this study was to compare 
concentrations measured in effluent and biosolids to levels reported in literature. The 
objectives were achieved by accomplishing the following tasks: 
1. collection of samples from three WWTPs  
2. extraction of biosolids by accelerated solvent extraction (ASE), followed by a 
clean up step, solid-phase extraction (SPE)  
3. extraction of influent and effluent samples using solid-phase extraction (SPE) 
4. analysis of sample extracts by liquid chromatography-mass spectrometry (LC-
MS) or gas chromatography-mass spectrometry (GC-MS).  
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LITERATURE REVIEW 
Physicochemical Properties of Selected Compounds  
 Ten PPCPs, listed in Table 2, were selected for this study based on their 
chemical properties, environmental concern due to their widespread use, frequent 
detection in natural water, wastewater, and biosolids, and potential risk to the 
environmental and human health.  
 The stimulant caffeine has not been reported to inflict any harmful effects at 
levels found in the environment, but was chosen as an anthropogenic tracer.  
 Acetaminophen is a widely used pain reliever and fever reducer. It has been 
shown that children prenatally exposed to acetaminophen are more likely to show 
symptoms of asthma (U.S. EPA 2010b).  
 Sulfamethoxazole is one of the most commonly prescribed antibiotics in the 
United States. Repeated reports of antibiotic-resistant bacteria found in wastewater and 
biosolids have raised a concern of antibiotic’s anthropogenic presence in the 
environment (Schwartz et al. 2003). In 2008 sulfamethoxazole was on the list of top 
prescriptions dispensed in the U.S. (RxList 2011).  
Table 2. Selected PPCPs and their uses 
 
Compound Abbreviation Use
Caffeine CAF Stimulant
Acetaminophen ACM Analgesic and antipyretic 
Sulfamethoxazole SMZ Antibiotic
Tris(2-chloroethyl) phosphate TCEP Flame retardant 
Carbamazepine CBZ Anticonvulsant and mood stabilizer
Estrone EST Reproductive hormone
Progesterone PRG Reproductive hormone
Gemfibrozil GEM Antihyperlipidemic
4-n-nonylphenol 4-NP Detergent metabolite 
Bis(2-ethylhexyl) phthalate DEHP Plasticizer
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 Flame retardant TCEP is utilized in the manufacturing of cars and aircraft, flame-
resistant paints, textile industry, etc. Exposure to tris(2-chloroethyl) phosphate is known 
to exhibit carcinogenicity and reproductive toxicity (Government of Canada 2009).  
 The anticonvulsant carbamazepine was found to be carcinogenic to rats and 
harmful to aquatic organisms (Fent et al. 2006; Santos et al. 2010).  
 Estrone and progesterone were selected to represent endocrine disruptive 
compounds (EDCs) that have been reported to impact sustainability of a fish population 
(MacLatchy et al. 2009) and sexual disruptions of wild fish (Jobling et al. 1998). Fatta-
Kassinos et al. (2011) in their review “Pharmaceutical residues in environmental waters 
and wastewater” state that hormonal medications and antibiotics are among the most 
frequently detected classes of pharmaceuticals.  
 Gemfibrozil is commonly prescribed to patients at risk of coronary disease. This 
pharmaceutical was also reported to have adverse effects on aquatic life; it was 
categorized as toxic to Hydra attenuate (Quinn et al. 2008) and classified as “harmful to 
aquatic organisms” (Zurita et al. 2007).  
 4-n-nonylphenol, a degradation byproduct of nonylphenol polyethoxylate 
surfactants used in domestic and industrial cleaning products, falls under the category of 
endocrine disruptive compounds (Hseu 2006; Roberts et al. 2006).  
 Another group of compounds that is frequently detected in the environment is 
plasticizers, represented here by bis(2-ethylhexyl) phthalate. Bis(2-ethylhexyl) phthalate 
increases flexibility of plastics and is mainly used in the production of PVC and vinyl 
chloride resins. The concern to the environment is due to its hepatotoxic, carcinogenic 
and teratogenic nature (Liang et al. 2008). In addition to birth defects and weight gain, 
oral exposure to bis(2-ethylhexyl) phthalate caused adverse effects on the kidney and 
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liver of study animals (U.S. EPA 2000). Bis(2-ethylhexyl) phthalate is classified as a 
“probable human carcinogen” (U.S. EPA 2000).  
 Concentrations of PPCPs in the aquatic environment largely depend on the 
chemical and physical properties of the compounds (Jones et al. 2005). Rogers (1996) 
states that the fate of organic contaminants during wastewater treatment depends on 
their physicochemical properties and degradability. Selected properties of each 
compound are presented in Figures 1 through 10.  
 
1Lide (1996), http://archemcalc.com/sparc/pKa/Full_Speciation.cfm?plot=1&CFID=21798&CFTOKEN=90463096,  2EPI 
Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, Hansch et al. (1995), 4EPI Suite, Yalkowsky and Dannenfelser 
(1992), 5Richardson and Bowron (1985). 
Figure 1. Caffeine 
 
1EPI Suite, Dastmalchi, S., et al. (1995), 2EPI Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, Sangster (1994), 
4Yalkowsky and Dannenfelser (1992), 5Richardson and Bowron (1985). 
Figure 2. Acetaminophen  
Caffeine Physicochemical Properties
CAS number: 58-08-2
C8H10N4O2
Molecular weight 194
1pKa 0.61, 3.6
2KH (atm-m3/mole) 3.58E-11
3log Kow -0.07
4Solubility (mg/L), 25 deg C 21,600
5Ready biodegradability prediction Yes
Acetaminophen Physicochemical Properties
CAS number: 103-90-2
C8H9N1O2
Molecular weight 151
1pKa 9.38
2KH (atm-m3/mole) 6.42E-13
3log Kow 0.46
4Solubility (mg/L), 25 deg C 1.40E+04
5Ready biodegradability prediction Yes
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1http://archemcalc.com/sparc/pKa/Full_Speciation.cfm?plot=1&CFID=21798&CFTOKEN=90463096, Lucida et al. (2000), 
2EPI Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, Hansch et al. (1995), 4EPI Suite, Yalkowsky and Dannenfelser 
(1992), 5Richardson and Bowron (1985). 
Figure 3. Sulfamethoxazole  
 
1Not applicable, 2EPI Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, KowWin estimate, 4Estimate from Log Kow 
(WSKOW v1. 41), 5Watts and Linden (2008). 
Figure 4. TCEP 
 
1Not applicable, 2EPI Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, Dal Pozzo et al. (1989), 4Ferrari et al. (2003), 
5Clara et al. (2004). 
Figure 5. Carbamazepine 
Sulfamethoxazole Physicochemical Properties
CAS number: 723-46-6
C10H11N3O3S
Molecular weight 253
1pKa 1.76, 5.6
2KH (atm-m3/mole) 9.56E-13
3log Kow 0.89
4Solubility (mg/L), 25 deg C 610
5Ready biodegradability prediction No
Tris(2-chloroethyl) phosphate Physicochemical Properties
CAS number: 140-08-9
C6H12Cl3O4P
Molecular weight 267
1pKa NA
2KH (atm-m3/mole) 1.10E-06
3log Kow 1.51
4Solubility (mg/L), 25 deg C 951.3
5Ready biodegradability prediction No
Carbamazepine Physicochemical Properties
CAS number: 298-46-4
C15H12N2O
Molecular weight 236
1pKa NA
2KH (atm-m3/mole) 1.08E-10
3log Kow 2.45
4Solubility (mg/L), 25 deg C 112
5Ready biodegradability prediction No
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1http://archemcalc.com/sparc/pKa/Full_Speciation.cfm?plot=1&CFID=21798&CFTOKEN=90463096, 2EPI Suite, 
HENRYWIN v3.20, Bond Method, 3EPI Suite, Hansch et al. (1995), 4Merck Index (1996), 5EPI Suite, BIOWIN.  
Figure 6. Estrone  
 
1Not applicable, 2EPI Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, KowWin estimate, 4Estimate from Log Kow 
(WSKOW v1. 41), 5EPI Suite, BIOWIN.  
Figure 7. Progesterone 
 
1http://archemcalc.com/sparc/pKa/Full_Speciation.cfm?plot=1&CFID=21798&CFTOKEN=90463096, 2EPI Suite, 
HENRYWIN v3.20, Bond Method, 3EPI Suite, KowWin estimate, 4Estimate from Log Kow (WSKOW v1. 41), 5Yu et al. 
(2006).   
Figure 8. Gemfibrozil 
Estrone Physicochemical Properties
CAS number: 53-16-7
C18H22O2
Molecular weight 270
1pKa 10.49
2KH (atm-m3/mole) 3.80E-10
3log Kow 3.13
4Solubility (mg/L), 25 deg C 30
5Ready biodegradability prediction No
Progesterone Physicochemical Properties
CAS number: 57-83-0
C21H30O2
Molecular weight 314
1pKa NA
2KH (atm-m3/mole) 6.49E-08
3log Kow 3.87
4Solubility (mg/L), 25 deg C 5.003
5Ready biodegradability prediction No
Gemfibrozil Physicochemical Properties
CAS number: 25812-30-0
C15H22O3
Molecular weight 250
1pKa 4.48
2KH (atm-m3/mole) 1.19E-08
3log Kow 4.77
4Solubility (mg/L), 25 deg C 5
5Ready biodegradability prediction Yes
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1http://archemcalc.com/sparc/pKa/Full_Speciation.cfm?plot=1&CFID=21798&CFTOKEN=90463096, 2EPI Suite, 
HENRYWIN v3.20, Bond Method, 3EPI Suite, Itokawa et al. (1989), 4Estimate from Log Kow (WSKOW v1. 41), 5Staples et 
al. (1999).  
Figure 9. 4-N-Nonyphenol 
 
1Not applicable, 2EPI Suite, HENRYWIN v3.20, Bond Method, 3EPI Suite, Debruijn et al. (1989), 4Defoe et al. (1990), 
5Rogers (1996). 
Figure 10. DEHP  
Biodegradability, one of the properties listed in Figures 1 through 10, is the 
capacity of chemical compounds to decompose by biological processes. A chemical is 
classified as “readily biodegradable” if it passes six test methods described in the 
Organization for Economic Cooperation and Development (OECD) Test Guidelines No. 
301 A-F.  
Stringent screening tests, conducted under aerobic conditions, in which a high 
concentration of the test substance (in the range of 2 to 100 mg/L) is used and 
biodegradation is measured by non-specific parameters like Dissolved Organic 
Carbon (DOC), Biochemical Oxygen Demand (BOD) and CO2 production. A 
positive result in a test for ready biodegradability can be considered as indicative 
of rapid and ultimate degradation in most environments including biological 
sewage treatment plants. (OECD 2005) 
4-n-nonylphenol Physicochemical Properties
CAS number: 104-40-5
C15H24O
Molecular weight 220
1pKa 10.68
2KH (atm-m3/mole) 5.97E-06
3log Kow 5.76
4Solubility (mg/L), 25 deg C 1.6
5Ready biodegradability prediction Yes
Bis(2-ethylhexyl) phthalate Physicochemical Properties
CAS number: 117-81-7
C24H38O4
Molecular weight 391
1pKa NA
2KH (atm-m3/mole) 1.18E-05
3log Kow 7.06
4Solubility (mg/L), 25 deg C 0.27
5Ready biodegradability prediction No
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The Ready Biodegradability Prediction of those target analytes for which 
experimental data were not available, was estimated using the Biodegradation 
Probability Program for Windows (BIOWIN), an individual model within the U.S. EPA 
Estimation Program Interface (EPI) Suite (U.S. EPA 2011c). In this study, the results of 
the ultimate biodegradation timeline model and the Ministry of International Trade and 
Industry (MITI) linear model were combined by BIOWIN to make a prediction. According 
to EPI Suite,  
The criteria for the YES or NO prediction are as follows:  If the Biowin3 (ultimate 
survey model) result is “weeks” or faster (i.e. days, days to weeks, or weeks) 
AND the Biowin5 (MITI linear model) probability is >= 0.5, then the prediction is 
YES (readily biodegradable).  If this condition is not satisfied, the prediction is NO 
(not readily biodegradable). 
In the biodegradation study conducted on the PPCPs predicted to be found in the 
River Lee in North London, caffeine and acetaminophen were identified as readily 
biodegradable (Richardson and Bowron 1985). Other studies report high removal 
efficiencies of acetaminophen (Yu et al. 2006; Al-Rifai et al. 2011). According to Al-Rifai 
et al. (2011), acetaminophen is effectively eliminated “due to its biodegradability.” Yu et 
al. (2006) found that aerobic biodegradation of acetaminophen in a WWTP that uses a 
biological nutrient removal (BNR) system was significant. This agreed with three out of 
four predictions by the BIOWIN models (Yu et al. 2006). The elimination of 
acetaminophen from a full-scale WWTP that employed a CAS process and dual 
membranes was evaluated by researchers in Australia. Efficient removal of 
acetaminophen was attributed to its high biodegradability (Al-Rifai et al. 2011). 
Richardson and Bowron (1985) classified sulfamethoxazole as non-biodegradable.  
Watts and Linden (2008) studied biodegradability of tris(2-chloroethyl) phosphate in 
water and found that it is not subject to biodegradation by conventional aerobic biological 
treatment processes. However, photooxidation facilitated greater than 95% removal of 
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tris(2-chloroethyl) phosphate in model lake water.  Carbamazepine was found to have 
low removal efficiencies and does not biodegrade or adsorb during wastewater 
treatment (Clara et al. 2004; Fent et al. 2006; Al-Rifai et al. 2011). The ready 
biodegradability prediction for estrone and progesterone was estimated using BIOWIN. 
According to the model, these compounds are not readily biodegradable. Gemfibrozil 
was classified as readily biodegradable, which was consistent with predictions by all 
BIOWIN models (Yu et al. 2006). Staples et al. (1999) measured biodegradability of 
nonylphenol and found that it qualified as readily biodegradable. Rogers (1996) found 
DEHP to be resistant to microbial degradation during an activated sludge process.  
In addition to biodegradation, another important chemical property that affects 
the fate of organic contaminants is the octanol-water partition coefficient (Kow). The Kow is 
an operational measure of the hydrophobicity of a chemical compound. In general, more 
hydrophobic compounds (high log Kow values) sorb to the solid phase, while hydrophilic 
compounds (low Kow values) have a greater affinity for the aqueous phase. Rogers 
(1996) suggests the following guidelines:  
• Log Kow <2.5    Low sorption potential 
• Log Kow >2.5 and <4.0  Medium sorption potential 
• Log Kow >4.0    High sorption potential 
 In the present research, compounds with high (above 4.0) log Kow values are: 
gemfibrozil, 4-n-nonylphenol, and bis(2-ethylhexyl) phthalate.  There is a high probability 
that these compounds sorb to the biosolids and thus may not be found in the effluent, or 
may be present at very low concentrations.  Caffeine, acetaminophen, 
sulfamethoxazole, tris(2-chloroethyl) phosphate, and carbamazepine are highly soluble 
in water, as indicated by small log Kow values, and are likely to be found in the effluent if 
not degraded.   
	  	  	   	  
14 
 Another criterion used to assess the fate of the PPCPs is volatility. Loss of 
organic compounds to volatilization can be estimated using the octanol-water partition 
coefficient and Henry’s constant (KH). Rogers (1996) recommends the following 
guideline: 
• KH >1x10-4 and KH/Kow >1x10-9  High volatilization potential  
• KH <1x10-4 and KH/Kow <1x10-9  Low volatilization potential  
None of the ten compounds investigated in this research fall under the category of 
having a high volatilization potential.  
 The following table, Table 3, is a summary of sorption potential defined by the 
octanol-water partition coefficient and volatilization potential based on both Henry’s law 
constant and the octanol-water partition coefficient (Rogers 1996). The fate prediction 
listed in Table 3 for each compound assumes the compounds are non-biodegradable.  
Table 3. Summary of fate implications for each PPCP 
 
	    
Compound Sorption potential defined by Kow
Volatilization potential 
based on KH and KH/Kow
Fate
CAF Low Low Effluent
ACM Low Low Effluent
SMZ Low Low Effluent
TCEP Low Low Effluent
CBZ Low Low Effluent
EST Medium Low Effluent and biosolids
PRG Medium Low Effluent and biosolids
GEM High Low Biosolids
4-NP High Low Biosolids
DEHP High Low Biosolids
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Removal of PPCPs by Various Wastewater Treatment Technologies  
 The first nationwide study on pharmaceuticals in wastewater was performed by 
the United States Geological Survey (USGS) in 1999 – 2000. Analysis of water samples 
from 139 streams in 30 states revealed the presence of organic wastewater 
contaminants.  The most frequently detected groups of chemical compounds include 
steroids, nonprescription drugs, insect repellents and detergent metabolites.  Reported 
concentrations were less than one part per million (mg/L), with detectable concentrations 
<1 µg/L. Several of the 95 compounds included in the USGS study exceeded drinking 
water guidelines, health advisories, or aquatic-life criteria. For example, concentrations 
of bis(2-ethylhezyl) phthalate exceeded its drinking water maximum contaminant level of 
6 µg/L at five sites under study (Kolpin et al. 2002). However, most of the compounds do 
not have such criteria or guidelines defined (Kolpin et al. 2002; Quinn et al. 2008). While 
the Pretreatment Program under the Clean Water Act regulates the quality of discharge 
from commercial facilities, there are no programs regulating household sewer discharge 
from private residences (U.S. EPA 2010a). Uncontrolled amounts of PPCPs continue to 
be discharged from households into WWTPs.  
 The concentration of PPCPs in wastewater effluents and biosolids largely 
depends on the treatment process implemented at a WWTP. Three treatment 
technologies, oxidation ditches, MBR, and trickling filters, are evaluated in this study. 
Each technology and its efficiency at eliminating PPCPs from wastewater influent are 
reviewed below.  
Trickling Filters (Spanish Fork WWTP) 
 A trickling filter is a nonsubmerged biological reactor consisting of rocks or plastic 
media of various shapes that accommodates development of a biofilm, a layer of 
biological microorganisms, as wastewater flows over the media (Tchobanoglous et al. 
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2003). The biofilm is responsible for wastewater treatment and biological degradation of 
pollutants (Shon et al. 2006). A study conducted on two wastewater treatment 
technologies in South Wales, UK concluded that PPCPs are more efficiently removed 
from wastewater by an activated sludge system deployed as an extended aeration 
oxidation ditch than a trickling filter treatment system (Kasprzyk-Hordern et al. 2009). In 
general, greater than 85% removal efficiency of 55 pharmaceuticals, sulfamethoxazole 
and carbamazepine among them, was observed by the activated sludge system. 
Trickling filter beds obtained a much lower efficiency, less than 70%. Removal of 70% of 
sulfamethoxazole was reported for the activated sludge treatment process. In contrast, 
no removal of this antibiotic took place at the plant with trickling filter beds. Stumpf et al. 
(1999) compared removal efficiencies of 11 polar drugs, including carbamazepine, and 2 
metabolites by the conventional activated sludge (CAS) treatment and a trickling filter. 
They concluded that compared to the CAS, trickling filters exhibited lower PPCP 
removal.  
Oxidation ditches (Brigham City WWTP)  
An oxidation ditch is a modification of a conventional activated-sludge process. It 
is an extended-aeration activated sludge process with a stable biomass. It is commonly 
used to treat wastewater from small communities (Viessman and Hammer 2005). The 
oxidation ditch consists of a channel, mechanical aerator and mixing devices. 
Wastewater, pretreated with screens, is fed into the ditch where it is combined with the 
return activated sludge (Tchobanoglous et al. 2003). The activated sludge is kept in 
suspension where formed biological floc reduces organic content of the sludge. Batt et 
al. (2007) explored occurrence of antibiotics, including sulfamethoxazole, in four full-
scale WWTPs, one of them being the extended aeration system, the system used in the 
oxidation ditches treatment process. The extended aeration combined with ferrous 
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chloride precipitation (not used in the treatment process of the Brigham WWTP) 
demonstrated higher removal efficiency than rotating biological contactors and pure 
oxygen activated sludge (Batt et al. 2007). Removal efficiency of sulfamethoxazole by 
extended aeration was reported at 75% reducing the influent concentration of 0.88 µg/L 
to 0.22 µg/L in the effluent.  
Membrane bioreactors (Hyrum City WWTP)  
 Membrane bioreactors (MBR) are a wastewater treatment technology that 
combines a biological reactor (bioreactor) and membrane filters that separate solids from 
treated water. Although both MBR and CAS use a biological activated sludge process to 
treat wastewater influent, MBR is considered superior due to the addition of membrane 
filters that may remove additional particulate matter producing higher quality effluent. 
There are two types of MBR. The type analyzed in this study, the integrated MBR, 
consists of cassettes made of multiple membranes immersed into the bioreactor. The 
other type is a recirculated MBR, where the mixed liquor is recirculated through the 
membrane modules situated outside the bioreactor (Tchobanoglous et al. 2003). Snyder 
et al. (2007) reported that concentrations of caffeine, acetaminophen, sulfamethoxazole, 
carbamazepine, and gemfibrozil decreased as the compounds passed through the pilot 
MBR with removal efficiencies varying between 99.1% (sulfamethoxazole) and 99.9% 
(acetaminophen). Radjenovic et al. (2009) found that the removal of acetaminophen 
from the aqueous phase by the MBR was greater than 99% (similar to the CAS). No 
elimination of gemfibrozil took place by CAS treatment, whereas 30-40% of this 
compound was eliminated by the MBR. In the same study, carbamazepine remained 
untreated by both technologies. Removal efficiencies of sulfamethoxazole were higher 
by the MBR technology (81%) than by the conventional activated sludge (75%).  
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MATERIALS AND METHODS 
Chemicals  
Individual stock solutions of all chemical compounds and an internal standard 
(d5-atrazine) were prepared from the pure compounds (>98%) in LC-MS grade methanol 
for the LC-MS analysis and methylene chloride for the GC-MS analysis. The combined 
stock spike solution and the internal standard spike solution were prepared in LC-MS 
grade methanol and methylene chloride using individual stock standards. The 
concentration of d5-atrazine spike solution was 250 µg/L. The concentrations of all 
PPCPs in the stock spike solution are given in Table 4. Target concentrations of all 
compounds were determined based on two parameters, the concentrations 
recommended by the U.S. EPA Method 1694 “Pharmaceuticals and Personal Care 
Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS” and limitations of the 
analytical sensitivity of the LC-MS and GC-MS. Calibration curve standards were 
prepared from individual stock solutions in 0.1% formic acid for LC-MS analysis and in 
methylene chloride for GC-MS. All standards were stored at 4°C.  
Table 4. Spike volume and concentrations of combined stock spike solution of native 
compounds 
 
CAF 30 26.70
ACM 30 100.0
SMZ 30 13.30
TCEP 30 13.30
CBZ 30 13.30
EST 30 33.30
PRG 30 13.30
GEM 30 13.30
4-NP 30 100.0
DEHP 30 100.0
Concentrations in stock 
spike solution, !g/LSpike volume, !LCompound
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Sampling Overview 
Grab samples of wastewater influent, effluent, and biosolids were collected from 
Brigham City, Hyrum, and Spanish Fork WWTPs in May, July and August of 2011. The 
influent samples were collected just before the influent enters the headworks. The 
effluent samples were collected immediately before the effluent enters receiving waters. 
All aqueous samples were collected into methanol-rinsed four-liter amber glass bottles.  
The biosolids samples were collected from the drying beds using stainless steel spoons 
and placed into 500 mL wide-mouth clear glass jars wrapped in aluminum foil. The 
samples were maintained in the dark at 4°C from the time of collection until their delivery 
to the Utah Water Research Laboratory (UWRL), where they were stored in the dark at 
<4°C until analysis. The aqueous samples were extracted using OasisTM HLB cartridges 
(500 mg, 6cc) and subsequently analyzed by LC-MS and GC-MS. The biosolids were 
extracted using a Dionex accelerated solvent extractor (ASE) followed by solid-phase 
cartridge clean up and analyzed by LC-MS and GC-MS. All samples were extracted 
within 14 days of collection and analyzed within 40 days of extraction (U.S. EPA 2007).   
Sample Preparation – Accelerated Solvent Extraction  
Accelerated solvent extraction (ASE) is used for the extraction of solid and 
semisolid samples at elevated pressure and temperature and is one of the most 
common procedures for biosolids extraction (Kinney et al. 2006; Ding et al. 2011). In this 
study, an automated Dionex-ASE 150 system (Dionex Co., Sunnyvale, CA) was used for 
the biosolids extractions. A cellulose single thickness soxhlet extraction thimble 
(Whatman, 25 mm x 90 mm) packed with ten grams of wet biosolids was inserted into a 
34-mL stainless steel ASE vessel. The thimble was sealed at both ends with 30 mm 
circular glass fiber filters (Dionex). Acid and base fractions were extracted separately, 
the acid fraction with 4:3 solvent solution of acetonitrile/phosphate buffer (pH 2±0.5) 
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prepared according to the Method 1694. The base fraction was extracted with a mixture 
of acetonitrile/water ratio of 4:3 (pH 10±0.5). The extraction temperature was set to 
120°C; other parameters included three 10-minute static pressurization cycles, solvent 
rinse volume of 40% and a purge time of 60 seconds. The final volume of the extract 
was approximately 70 mL.  
Following the ASE, the extracts were concentrated to an approximate volume of 
3 mL using a TurboVap II (Caliper Life Science, Hopkinton, MA) set at 59°C and 18 psi 
in preparation for the SPE cleanup step (Ferrer and Furlong 2002). The volume of each 
concentrate was brought to 50 mL with reagent water (deionized water) and the samples 
were centrifuged for 15 minutes at 7000 rpm in 50 mL Q-sep Teflon FEP centrifuge 
tubes (Restek). After centrifugation, the volume the supernatant (acid fraction) was 
brought to 200 mL with reagent water adjusted to pH 2.0±0.5 with H3PO4. Five hundred 
mg of 500 mg of tetrasodium ethylenediamine-tetraacetate dihydrate 
(Na4EDTA.2H2O•2H2O) was also added. The supernatants of the base fraction were 
also diluted to 500 mL with reagent water but the pH was adjusted to 10.0±0.5 with 
NH4OH.   
Sample Preparation – Solid Phase Extraction  
The most common techniques for extraction of pharmaceuticals from wastewater 
include solid-phase extraction (SPE) and solid-phase microextraction (SPME). Liquid-
phase microextraction (LPME), and lyophilization have also been applied (Fatta-
Kassinos et al. 2011).    
In this study, influent (300 mL) and effluent (500 mL) samples were extracted 
using OasisTM HLB (divinylbenzene and N-vinylpyrrrolidone monomers) cartridges (500 
mg, 6 cc) manufactured by Waters (Mildford, MA) following the general procedure 
documented in U.S. EPA Method 1694 (U.S. EPA 2007). The acid and base fraction of 
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each sample was extracted separately. For the acid fraction, 500 mL of effluent and 300 
mL of influent sample were extracted. Six 500 mL glass wide-mouth Erlenmeyer flasks 
were labeled and weighed. Two flasks filled with approximately 500 g of reagent water 
were designated for a laboratory blank sample and a laboratory control spike (LCS); the 
remaining four flasks were filled with the aqueous sample. Two aqueous samples 
represented duplicate samples and the other two duplicate matrix spikes. The pH of all 
four samples was adjusted to 2.0±0.5 with H3PO4. Aqueous samples with visible 
particles were filtered using Whatman GF/A glass fiber filters. LCS and MS were spiked 
with a known amount of native compounds. Spike concentrations and volumes are given 
in Table 4. The acid fraction, including QC aliquots, was stabilized with 500 mg of 
Na4EDTA.2H2O•2H2O (U.S. EPA 2007). Samples and QC aliquots were allowed to 
equilibrate for 1 to 2 hours. SPE cartridges were attached to an Agilent Technologies 12-
port vacuum extraction manifold. The cartridges were conditioned by eluting 20 mL of 
LC-MS grade methanol and 16 mL of reagent water at pH 2.0±0.5 (acid fraction) or 16 
mL of reagent water (base fraction). Prepared samples were loaded into the cartridges 
at a flow rate of 10 mL/min. Once most of the samples have passed through the 
cartridges the flasks were rinsed with approximately 5 mL of reagent water (at pH 
2.0±0.5 for acid fraction). After the entire sample had passed through, the acid fraction 
cartridges were washed with 40 mL of reagent water at pH 2.0±0.5. Both fractions were 
then vacuum-dried for approximately 15 minutes. Each acid fraction analyte was eluted 
with 40 mL of LC-MS grade methanol; base fraction analytes were eluted with 30 mL of 
LC-MS grade methanol followed by 10 mL of 2% formic acid solution, prepared 
according to the U.S. EPA Method 1694. The eluents were collected in 50 mL 
Erlenmeyer flasks and equally divided between two glass tubes preceding solvent 
reduction by TurboVap II and solvent exchange. The extracts were concentrated with 
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nitrogen gas to 0.5 mL at 15-20 psi and a water temperature of 59°C. Further, the LC-
MS fraction of the samples was brought to the final volume of 1.5 mL with 0.1% formic 
acid solution prepared in reagent water, transferred into 2 mL GC vials and refrigerated, 
if not immediately analyzed. Exactly 1.5 mL of each extract was transferred into a 2 mL 
MCT graduated micro centrifuge tube (Fisherbrand) and centrifuged at 10,000 rpm for 
10 minutes in 22331 Eppendorf AG centrifuge (Hamburg, Germany). Finally, 1.0 mL (or 
1.25 mL) of the centrifuged extract was transferred into a 2 mL clear glass vial for LC-
MS analysis and spiked with 5 µL (or 6.3 µL) of 250 µg/L internal standard, d6-atrazine. 
The GC-MS fraction of each sample was brought to approximately 2 mL with methylene 
chloride and passed through a 5-¾ inch glass pipet packed with glass wool and sodium 
sulfate. The final volume of the extract was weighed.  
Quality Assurance/Quality Control  
Calibration curve standards of 50, 100, 250, 500, 750, 1000 µg/L concentrations 
were prepared in 0.1% formic acid (in reagent water) for the LC-MS analysis and in 
methylene chloride for the GC-MS analysis. Extraction efficiencies were evaluated using 
with laboratory control spikes (LCSs) and matrix spikes (MSs). Continuous calibration 
verification (CCV) samples were used every 10 samples during LC-MS and GC-MS 
analyses.  The internal standard, d6-Atrazine, was added to all samples and quality 
controls (QC) (U.S. EPA 2007).  
Laboratory Control Spikes  
Laboratory Control Spikes for aqueous samples were prepared by spiking 
reagent water with a known amount of target analytes (Table 4); 300 mL and 500 mL of 
reagent water was used for influent and effluent extractions, respectively. LCSs for 
biosolids extractions were prepared by spiking unfilled soxhlet extraction thimbles with a 
known amount of target PPCPs. The LCSs were extracted following the procedures 
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described in the Materials and Methods section and were used to verify the 
effectiveness of the extraction procedures. 
Matrix Spikes  
Matrix spikes and matrix spike duplicates were prepared for each sample type 
(influent, effluent, and biosolids) or each matrix type (aqueous and biosolids) by spiking 
300 mL and 500 mL of influent and effluent respectively, and 10 g of biosolids with a 
known amount of target analytes (Table 4). Matrix spikes were extracted following the 
procedure used for samples.  
Analytical Methods 
LC-MS or GC-MS was used to analyze sample extracts for selected compounds 
(Table 2). A 6220 Accurate-Mass TOF LC/MS (Agilent Technologies, 1200 Series) and a 
6890 Series GC System and 5973 Mass Selective Detector (Hewlett Packard), were 
utilized. Bis(2-ethylhexyl) phthalate and 4-n-nonylphenol were analyzed by the GC-MS; 
the rest of the compounds were analyzed by the LC-MS.  
The analytes were separated by the LC-MS equipped with a C-18 (10 cm long, 
1.8 µm packing, 4.1 mm diameter, 0.35 mL/min flow rate) rocket column (Agilent 
Technologies). Mobile phase A was prepared using a 9:1 ratio of acetonitrile to water 
solution; mobile phase B consisted of 0.1% solution of formic acid in reagent water. The 
injection volume of 5 µL was used in the LC-MS.  
Bis(2-ethylhexyl) phthalate and 4-n-nonylphenol were analyzed by the GC-MS 
equipped with an RTX – 5 (30 m long, 0.25 mm diameter) capillary column (Restek). The 
flow rate of helium, the carrier gas in the GC-MS, was 37 cm/sec; injection volume was 
equal to 1 µL. 
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RESULTS AND DISCUSSION 
Statistical Analysis  
All statistical analyses were performed in R, “a language and environment for 
statistical computing and graphics,” available for download at <http://www.r-project.org/> 
(April 26, 2012). Residuals were checked to verify a normal distribution of the data 
(Appendix A). 
Quality Assurance/Quality Control  
Laboratory Control Spikes  
LCSs were prepared and analyzed for each sample type and sampling trip during 
the month of May. However, only one LCS for each sample matrix was prepared in the 
laboratory and extracted along with the samples collected from the three WWTPs in July 
and August. The average percent LCS recoveries and the standard deviations (n=5) are 
given in Table 5. 
The influent and effluent LCS recoveries were >80% for all compounds except for 
progesterone, gemfibrozil, 4-n-nonylphenol, and bis(2-ethylhexyl) phthalate. The 
biosolids LCS recoveries were <55% for all compounds. 
Table 5. Average LCS percent recoveries 
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LCS recoveries of acidified samples  
Consistent with the U.S. EPA Method 1694 (U.S. EPA 2007), all samples were 
extracted at two pHs, 2±0.5 and 10±0.5. LCS samples were also prepared at three 
different pHs, 2±0.5, 10±0.5 and unadjusted (approximately pH 7), were extracted and 
analyzed to determine the optimal extraction pHs. Figure 11 presents results of the LCS 
recoveries achieved at three different pH levels. 
 
Figure 11. LCS recoveries for LCS samples extracted at pH 2±0.5 (acid), pH 10±0.5 
(base) and unadjusted pH (neutral) 
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According to the outcome of Tukey’s test (Appendix B), the LCS recoveries of 
acidified samples are different from recoveries achieved at pH 10±0.5 (the 95% 
confidence interval (CI) does not include zero and the probability value is <0.05). Figure 
11 shows that these recoveries are higher than the recoveries of samples extracted at 
neutral pH and pH 10±0.5.  Therefore the data presented hereafter are the results of the 
analysis performed on the samples extracted at pH 2±0.5. Gemfibrozil was not 
recovered in any of the LCS and will not be reported.  
Matrix Spikes  
Matrix Spikes (MS) were extracted and analyzed for the influent and effluent 
samples collected in July and August and for biosolids collected in all three sampling 
months. The amount of each compound detected in the sample was calculated by 
multiplying the concentration of each compound in the final extract by the volume of the 
final extract. The average amount of each compound found in a sample was subtracted 
from the amount detected in a matrix spike sample and divided by the amount of the 
compound added to the matrix spike sample.  
A paired t-test and Tukey’s test were conducted on MS samples. Paired t-tests 
performed on the influent and effluent MS recoveries (95% confidence interval includes 
zero and p value>0.05) verified that the means of MS recoveries for each, the influent 
and effluent matrix spikes from two sampling events, were statistically equivalent. 
Tukey’s test was used to verify that the potential matrix variation between the sampling 
events (May, July, and August) had no impact on percent recoveries of biosolids matrix 
spikes. The results of the statistical analyses (95% confidence interval includes zero and 
p adj>0.05) allowed averaging the MS data for each sampling location over the three 
sampling events, as presented in Tables 6 through 8.  
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Table 6. Influent matrix spike recoveries 
 
Table 7. Effluent matrix spike recoveries  
 
!"#$ %"&"'() !"#$ %"&"'() !"#$ %"&"'()
*%+ ,-.- /,.0 -/.1 23.4 3-., ,40.5
%*6 -.3 7/.8 ,4.5 -0., -2.- ,5/.,
96: 80.8 80.0 8,.2 -/.3 8,.1 0-.-
;*<= -8., 28.2 82.0 28.0 --./ 2,.,
*>: /-./ 11.2 -1.5 50.3 08.- 11.5
<9; 05.8 08.1 /2.5 3/., //.3 54.,
=?@ -3.4 02./ 00.1 32.3 0,.2 14.2
@<6 33., 4.4 -1.1 4.4 ,4.3 4.4
07A= 8-1.8 4.4 823.- 4.4 8,2.5 4.4
B<C= -0.8 3.0 2/./ 8/.8 38.5 ,5.3
*DEFD"GH >IJ&KLE C$I"E 9FLGJ'K)+DIM
!"#$ %"&"'() !"#$ %"&"'() !"#$ %"&"'()
*%+ ,-./ 01., 2-.0 32.4 31.5 -2.1
%*6 1,.5 25.2 7-.4 0./ 77.4 21.0
869 10.0 15.3 1/.2 2/./ 7.5 7.5
:*;< ,-.0 03., ,2.4 52.1 21./ 5,.2
*=9 00.5 -5.3 0-.2 -0.1 22., -,.5
;8: 0,.7 ,-.5 33.- 03., 775.0 71,.5
<>? 0,.7 01.7 1,./ 45.1 03.7 771.1
?;6 1/.1 70.4 -.1 22.1 2,.2 27.1
,@A< 15., /./ 7., /./ -5.- /./
B;C< ,1.4 77.0 34.2 2,.1 13.5 7.-
*DEFD"GH =IJ&KLE C$I"E 8FLGJ'K)+DIM
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Table 8.  Biosolids matrix spike recoveries 
 
Low matrix spike recoveries (<50%) can be caused by the complex matrices of 
wastewater samples, inefficient extraction of the analytes during the ASE procedure 
and/or potential loss of the analytes during the SPE cleanup step (Ding et al. 2011).  
Due to low biosolids MS recoveries, the biosolids data are not included in further 
analysis. 
The influent and effluent BOD concentrations and the biosolids total carbon 
content for each sampling month were obtained from each plant.  Generally, MS 
recoveries decrease with an increase in BOD and carbon content. However, these 
trends were not statistically significant.  
Limit of quantitation  
The limit of quantitation (LOQ), as defined by the U.S. EPA,  
is the level above which the analytes may be quantified with a specific precision, 
often ± 30%. This precision is usually assumed to occur at ten times the standard 
deviation measured for the instrument detection limit. (U.S. EPA and Smith 1991)  
 
 
!"# $%&# '%(%)* !"# $%&# '%(%)* !"# $%&# '%(%)*
+', -./ -.0 12.3 4.- 53.- /5.1 6.5 6.7 50.1
'+! 7./ 3.5 33.- 87.5 7.2 7.1 7.1 7.1 35.7
9!: 7.7 7.7 7.- 7.7 5.1 7.4 1.3 3.2 7.1
;+<= 51.6 /1.1 13.5 67.2 4/.5 //.1 51.3 /2.5 17.4
+>: /6.2 50./ 53.7 41.4 50.7 51.3 /7.2 5-.- 3-.5
<9; --.2 7.7 7.7 /6.- -.3 54.- 34.4 5-.5 7.7
=?@ 1.3 7.7 2.- 4./ 8/.5 7.0 -./ /.1 /.4
@<! 7.7 31.4 7.7 5.4 7.7 30.- 7.7 2.4 30.4
18A= 54.6 7.7 6.7 7.7 7.7 7.7 4-./ 7.7 5.1
B<C= /.5 /.7 87./ 835.5 3.1 5.7 37.4 3.0 5.6
+DEFD%GH >IJ(K"E 9F"GJ)KL,DIMC#I%E
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Table 9. Mass of target analytes added, average mass recovered (n=7), and LOQ 
 
The LOQ was used as a conservative guideline in censoring and reporting data. 
Seven samples were prepared by spiking 500 mL of reagent water with a known amount 
of the target analytes (Table 9) and extracted following the extraction procedure for 
acidified aqueous samples described in the Materials and Methods section. The 
standard deviations were calculated based on the seven concentrations of each target 
analyte detected in each extracted sample and multiplied by 10 for the LOQ results. 
Table 9 gives the mass of each target analyte added to each sample prior to extraction, 
the average recovered mass (n=7) and the standard deviation, as well as the calculated 
LOQ.  
Only six of the original ten compounds were selected for further data analysis 
(Table 10). These compounds had relatively high spike recoveries and consistent 
detection in the influents above the LOQs. The other four compounds, estrone, 
progesterone, gemfibrozil and 4-n-nonylphenol, were eliminated from further discussion 
due to analytical problems (i.e. low spike recoveries, high blank concentrations) or 
inconsistent detections in the influent samples.  
!"# $%$&' $%$()*+*$%$$&( $%$,-
"!. $%$/0 $%$$)*+*$%$$/( $%$(-
1.2 $%$/0 $%$/0*+*$%$$$0 $%$/,
3!45 $%$/0 $%$/,*+*$%$$(& $%$-)
!62 $%$/0 $%$//*+*$%$$$- $%$$0
413 $%$)$ $%$,(*+*$%$/&7 $%())
589 $%$(, $%$/&*+*$%$$/$ $%$($
94. $%/$' $%$-&*+*$%$((' $%--0
-:;5 $%)$$ $%/,7*+*$%/$,) (%/&&
<4=5 $%$)$ $%/-0*+*$%$'07 /%/),
!>?@>ABC .DEE*DCCFCG*HI .DEE*JFK>LFJFCG*HI MNOG*HIPM
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Table 10. Selected properties of six PPCPs 
 
Influent 
Concentrations of the six target analytes detected in the influent samples of 
Brigham, Hyrum and Spanish Fork WWTPs in May, July, and August are presented in 
Figures 12 through 14, respectively. Caffeine, acetaminophen, and sulfamethoxazole 
were detected in the influent of all WWTPs during all sampling months. Tris(2-
chloroethyl) phosphate, carbamazepine, and bis(2-ethylhexyl) phthalate show variability 
in concentrations over sampling trips, but were detected in the influent of all WWTPs 
during one or two out of three sampling months, except for bis(2-ethylhexyl) phthalate. In 
August, the concentrations of bis(2-ethylhexyl) phthalate were <LOQ in all WWTPs. The 
highest influent concentrations for caffeine (15.4 µg/L) and acetaminophen (71.5 µg/L) 
were recorded for the Spanish Fork WWTP in the month of May. Sim et al. (2010) also 
found that concentrations of caffeine and acetaminophen were the highest among 25 
compounds measured in the municipal wastewater influent in Korea. The measured 
concentrations of all compounds, with an exception of bis(2-ethylhexyl) phthalate, are 
similar to those reported in literature (Table 11). Concentrations of this compound 
documented by Barnabe et al. (2008) are higher than the concentrations detected in the 
present study.  
CAF 0.61, 3.6 neutral 21,600 -0.07 yes
ACM 9.38 neutral 1,400 0.46 yes
SMZ 1.76, 5.6 negative 610 0.89 no
TCEP NA neutral 951 1.51 no
CBZ NA neutral 112 2.45 no
DEHP NA neutral 0.27 7.6 no
Compound pKa Charge at pH 7 Solubility, mg/L log Kow
Bio-
degradability 
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Figure 12. Concentrations of the target analytes in wastewater influent collected from the 
Brigham, Hyrum, and Spanish Fork WWTPs in May 2011. Error bars represent 95% 
confidence interval of duplicate samples. 
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Figure 13. Concentrations of the target analytes in wastewater influent collected from the 
Brigham, Hyrum, and Spanish Fork WWTPs in July 2011. Error bars represent 95% 
confidence interval of duplicate samples (where available). 
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Figure 14. Concentrations of the target analytes in wastewater influent collected from the 
Brigham, Hyrum, and Spanish Fork WWTPs in August 2011. Error bars represent 95% 
confidence interval of duplicate samples. 
  
0
10
20
30
40
50
60
CAF ACM SMZ TCEP CBZ DEHP
Brigham
Hyrum
Spanish Fork
C
on
ce
nt
ra
tio
n,
 !
g/
L
Compound
!"#$%!"#$%
	  	  	   	  
34 
Table 11. Wastewater influent, effluent, and biosolids concentrations of selected 
compounds reported in literature (standard deviation where available) 
 
 
 
Note: LOQ limits of quantification (Lacey et al. 2012), ND not detected (Jackson and 
Sutton 2008), LOD limits of detection (Lacey et al. 2012). 
 
1Lacey et al. (2012), 2Sim et al. (2010), 3Gomez et al. (2007), 4Karnjanapiboonwong et 
al. (2011), 5Radjenovic et al. (2009), 6Li et al. (2009), 7Batt et al. (2007), 8Jackson and 
Sutton (2008), 9Kim et al. (2007a), 10Ferrari et al. (2003), 11Barnabe et al. (2008), 
12Dargnat et al. (2009) 
 
Effluent 
The compounds with the highest concentrations measured in the effluents of all 
three WWTPs were sulfamethoxazole and carbamazepine (Table 12). The 
concentrations of caffeine and acetaminophen were below the LOQ in the majority of the 
effluents. The effluent concentrations bis(2-ethylhexyl) phthalate were consistently 
<LOQ. Similarly, other authors were able to detect only 14 out of 25 compounds in the 
effluent stream of a WWTP in Dublin, Ireland (Lacey et al. 2012). In that study, several 
compounds, including carbamazepine, were measured at higher concentrations in the 
effluent than in the influent (Lacey et al. 2012).  
!"#$"%&' Influent Concentration Author !g/L Effluent Concentration Author !g/L
LOQ-3.791, 3.37±1.942, LOQ-2.71, 0.0242,
52-1923 1.4-443, ND-0.344
ND2, <LOD-4.33
7.1-11.45(primary effluent),
0.25-1.35(primary effluent),
0.0153±0.0003 – 0.0466±0.00266,
0.22±0.2 – 0.68±0.037
(!)* ND/<1.25 – ND<58, 0.2849 ND/<0.25 – 0.3738
LOD-0.151, LOQ-6.51, 0.178±0.0402,
0.288±0.1192, 0.054-0.225(primary effluent),
0.12-0.313 0.11-0.233, 0.30-1.2010
+),* 57.0±7.4 – 80.0±10.411 54±7.011,  5.02±1.5312
6.80±2.412, 29-2463
!-.
-!/
0/1
!21
0.1465±0.0106 – 0.3555±0.01726, 
0.88±0.087
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Table 12. Average (n=2) effluent concentrations measured at the Brigham, Hyrum, and 
Spanish Fork WWTPs 
 
The concentrations of three compounds (sulfamethoxazole, tris(2-chloroethyl) 
phosphate, and carbamazepine) were >LOQ in the effluents of all WWTPs. These 
effluent concentrations are similar to those reported by other authors (Table 11). For 
example, the range of sulfamethoxazole concentrations in the effluent of five WWTPs in 
Erie County, New York was reported between 0.22-0.68 µg/L (Batt et al. 2007). 
However, concentrations of sulfamethoxazole in the effluent of Hong Kong WWTPs are 
an order of magnitude lower, 0.0153-0.0466 µg/L (Li et al. 2009). 
The concentrations of tris(2-chloroethyl) phosphate detected in the effluent of 
WWTPs in Oakland, CA ranged between <0.25 µg/L and 0.373 µg/L (Jackson and 
Sutton 2008). As reported by multiple authors, concentrations of carbamazepine vary in 
different parts of the world, 0.054-6.5 µg/L (Ferrari et al. 2003; Gomez et al. 2007; Sim et 
al. 2010; Lacey et al. 2012). 
Fate 
Based on the selected properties of six PPCPs, estimates of the fate of each 
compound in the WWTP were made. Biodegradability data combined with the log Kow 
values were used to predict the likelihood of each compound’s occurrence in the effluent 
and/or biosolids.  
!"#$%&' ()"*' +,&-#.%/01"2 !"#$%&' ()"*' +,&-#.%/01"2 !"#$%&' ()"*' +,&-#.%/01"2
340 5678 9:;< <:=> 5678 5678 9:>9 5678 5678 <:?@
43A 5678 9:9B 9:9? 5678 5678 5678 5678 5678 5678
+AC 9:9D 9:;E 9:<9 9:9? 9:9> 9:9E 9:<? 9:<= 9:9E
F3GH 5678 9:<E 9:<< 9:9? 9:9; 9:9D 9:9> 9:9? 9:<9
3!C 9:9E 9:9B 9:9B 9:9E 9:9E 9:9; 9:9; 9:9< 9:9B
IG(H 5678 5678 5678 5678 5678 5678 5678 5678 5678
A&) J*K) 4*$*.L31',1*-M
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Figure 15. Fate prediction based on the log Kow value and biodegradability 
The schematic presented here (Figure 15) suggests that less biodegradable 
compounds with low Kow values (<2.5) are more likely to leave a WWTP with the effluent 
and less biodegradable compounds with high log Kow values (>4.0) are more likely to 
leave the WWTP with the biosolids (Rogers 1996).  
For highly biodegradable compounds, it is predicted that they would not be found 
in the effluent or biosolids. Caffeine and acetaminophen are reported to be 
biodegradable (Richardson and Bowron 1985) and would not be expected to be present 
in either the effluent or biosolids. Sulfamethoxazole, the only negatively charged 
compound at environmentally relevant pH levels in this study, is highly soluble but not 
biodegradable, and is therefore, expected to be found in the wastewater effluent. Non-
biodegradable compounds with low log Kow values, tris(2-chloroethyl) phosphate and 
carbamazepine, should leave a WWTP with the effluent. Bis(2-ethylhexyl) phthalate is a 
less biodegradable compound with a high log Kow value (Rogers 1996). This implies that 
this compound is likely to leave a WWTP with the biosolids.  
WWTP INFLUENT  
High log Kow 
BIOSOLIDS 
Non-biodegradable  
Low log Kow 
EFFLUENT 
Non-biodegradable  
BIODEGRADED  
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Removal Efficiencies  
The efficiency of the three WWTPs and their wastewater treatment technologies 
in removing six PPCPs was calculated from differences in the influent to the effluent 
concentrations using equation (1). In this calculation the LOQ values were used in place 
of the effluent concentrations when they were <LOQ.  %  !"#$%&' =    (!!"!!!"")!!" ∗ 100%       (1) 
where Cin and Ceff  are average concentrations in the wastewater influent and effluent, 
respectively. As presented in Table 13, the removal efficiency is highly variable between 
compounds and WWTPs.  
Three compounds, caffeine, acetaminophen, and sulfamethoxazole, 
demonstrated the highest removal efficiencies by all three WWTPs (Table 13). Nearly 
complete removal of acetaminophen was observed from the aqueous phase of all three 
WWTPs. Elimination of caffeine was also highly effective (80.5 – >99.4%).  Although, 
sulfamethoxazole is defined by Richardson and Bowron (1985) as non-biodegradable, 
high removal efficiency of this compound was also observed (59.3 – 94.2%). These 
results are consistent with the log Kow/biodegradability fate predictions described earlier.  
Table 13. Monthly removal of PPCPs by Brigham, Hyrum, and Spanish Fork WWTPs 
 
Note: (*) – Effluent concentration > influent concentration 
!"#$%
&'(%#")"*+ ,- !./ &0 ,- !./ &0 ,- !./ &0
1"23"4#5 .67*%82 9+642 :38#7;%<0"6= .67*%82 9+642 :38#7;%<0"6= .67*%82 9+642 :38#7;%<0"6=
1>0 ?<@ABA @CBD AEBE ?<@ABF ?<@ABG AGB@ ?<@@BC ?<@@BD AHBI
>1! ?<@@B@ @@B@ @@B@ ?<@@BA ?<@@BE ?<@@BA ?<@@B@ ?<@@B@ ?@@B@
:!J @HB@ I@BG @CBK ECB@ LMN AABA AGBK EIBG @HBC
&1OP ?<IKBK CCBG FABD LMN LMN D@BE LMN KABK LMN
1.J KHBA LMN FCB@ LMN LMN LMN LMN G@BC LMN
-O9P ?<KBE ?<GCBK ?<@EBG ?<KHBH ?<GCBC ?<GKBA QR,S QR,S QR,S
!8+ T4)+ >4*4;$
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Table 14. Removal efficiencies reported in literature 
 
As shown in Table 14, the removal efficiencies achieved for all compounds are 
within the range of concentrations documented by other researchers. Kim et al. (2007a) 
documented significant removal (>95%) of the endocrine-disruptor tris(2-chloroethyl) 
phosphate by membrane filtration processes using reverse osmosis and nanofiltration in 
the study with full- and pilot-scale wastewater treatment processes. In the same study 
MBRs showed no removal (0.35%) of tris(2-chloroethyl) phosphate.  The presence of 
this compound in the effluent of all three WWTPs and its highly variable removal 
efficiency indicate that the compound is not completely eliminated by the wastewater 
treatment processes of the three WWTPs examined in this study.  
In the study on the performance of a full-scale CAS treatment and two pilot-scale 
MBR in removing 31 PPCPs, the elimination of carbamazepine from the aqueous phase 
was <10% (Radjenovic et al. 2009). No removal of the antiepileptic carbamazepine from 
the aqueous phase of several WWTPs in Austria was reported (Clara et al. 2005). 
Different authors also state that the effluent concentrations of this compound were 
frequently higher than its influent concentrations, similar to our findings (Clara et al. 
2005; Radjenovic et al. 2009). Consistent with the log Kow/biodegradability fate 
prediction, carbamazepine was detected in the effluent of all three WWTPs. The removal 
of this compound is variable between the WWTPs and the sampling months.  However, 
!"#$"%&' ()#"*+,-./)$"/0)'.1&.,10)/+0%/)
!23 445.671#.)0.+,8.9:;:<
2!= 445.671#.)0.+,8.9:;:<
7=> ?98@AB98C5.6>D"%.)0.+,8.9::4<E.FB89A4?8@5.6G1.0.+,8.9::4<E.@?5.6H+00.)0.+,8.9::@<
I!JK :8C?A4?5.6L1#.)0.+,8.9::@+<
!H> @5.6I)/&)-.;44B<E.9:5.6M+NO-"&.+&'.7%00"&.9::B<E.P98BA?P8C5.6>D"%.)0.+,8.9::4<
QJRK @B8;5.6Q+/S&+0.)0.+,8.9::4<
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the achieved removals are comparable with those reported by other researchers (Table 
14).  
The elimination of bis(2-ethylhexyl) phthalate, demonstrated by the three 
WWTPs in Utah, is significantly lower than the removal reported by Dargnat et al. (2009) 
(78.1%). According to the fate analysis, bis(2-ethylhexyl) phthalate is expected to 
partition into the biosolids and, therefore, its concentrations should be higher in the 
biosolids than in the effluent. However, due to low biosolids MS recoveries, comparison 
of bis(2-ethylhexyl) phthalate concentrations in the effluent to those in the biosolids 
cannot be made. Yet, its effluent concentrations below the LOQ may be indicative of the 
correct fate assumption for this compound.  
Figure 16 illustrates the maximum removal of each PPCPs achieved by the three 
WWTPs in Utah over a three-month sampling period. Tukey’s test was conducted on the 
removal efficiency data obtained for each WWTP in May, July, and August of 2011. To 
perform Tukey’s test the data were adjusted (negative values were made positive by 
adding the same value to each data point within each sampling month) and log 
transformed (Appendix C). The data analysis was performed in R. The test results 
suggest that there is no statistical difference in the performance of the WWTPs in 
eliminating the six PPCPs from the wastewater influent. Therefore, the treatment 
technologies, represented by the Brigham, Hyrum, and Spanish Fork WWTPs, do not 
differ in removing the six PPCPs investigated in this study. 
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Figure 16. Maximum percent removals of six PPCPs by Brigham, Hyrum and Spanish 
Fork WWTPs 
Toxicity   
Multiple studies have shown that the use of PPCPs and their inadequate 
treatment by WWTPs cause their appearance in receiving waters (Kolpin et al. 2002; 
U.S. EPA 2010a) and ultimately drinking water (Weinberg et al. 2004). However, there 
are insufficient data on toxicity, health effects, and safety threshold values of PPCPs.  
Research is underway to determine the effects of PPCPs on human health and the 
environment. Available data are often limited to a single organism or single compound 
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toxicity study. Presently, there are no data indicating a concern for negative effects on 
humans caused by PPCPs found in wastewater effluent. However, there are laboratory 
studies that show negative effects on aquatic organisms, fish in particular, associated 
with low concentrations (ng/L) of pharmaceuticals and estrogenic chemicals (U.S. EPA 
2010a).   
Toxicity data obtained in the study on the cnidarian, Hydra attenuate by Quinn et 
al. (2008) was categorized according to the measured effective concentration (EC50) 
value, a measure of toxicity of a chemical. Lower values of EC50 indicate higher levels of 
toxicity. Based on this classification, carbamazepine was reported to be toxic to Hydra 
attenuate with EC50 values between 10 and 100 mg/L; sulfamethoxazole and caffeine 
were found to be non-toxic (EC50 > 100 mg/L) (Quinn et al. 2008).  
In another study that investigated aquatic toxicity of acetaminophen, 
sulfamethoxazole, and carbamazepine on three test organisms, a marine bacterium 
(Vibrio fischeri), a freshwater invertebrate (Daphnia magna) and the Japanese medaka 
fish (Oryzias latipes), Daphnia magna was the most sensitive to most PPCPs tested 
(Kim et al. 2007b). For acetaminophen, the 48-hour D. magna EC50 value was recorded 
at 30.1 µg/L. It was concluded that sulfamethoxazole was not acutely toxic to Japanese 
medaka (LC50>100 mg/L). For carbamazepine, the median effective concentrations for 
V. fischeri and D. magna were 52.5 mg/L (5 minute exposure) and 76.3 mg/L (96 hour 
exposure) respectively (Kim et al. 2007b). The concentrations of acetaminophen, 
sulfamethoxazole, and carbamazepine (µg/L) measured in the effluent of Brigham, 
Hyrum and Spanish Fork WWTPs are much lower than those classified as toxic by 
Quinn et al. (2008) and below the EC50 value identified by Kim et al. (2007b).  
Effects of acetaminophen on the embryonic development of zebrafish, Danio 
rerio, were investigated by David and Pancharatna (2009). They found that low 
concentrations of acetaminophen (≥1 µg/L) increased the rate of mortality of the 
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exposed embryos, inhibited the body length and mass, and limited their life span. 
However, almost complete removal of acetaminophen from the wastewater treatment 
influent (>99.7%) and effluent concentrations of <0.1 µg/L suggest that this compound 
would not impose negative effects, similar to those described by David and Pancharatna 
(2009), to the aquatic life.  
The tris(2-chloroethyl) phosphate EC50 value of 126 mg/L was determined for 
algae, Tetrahymena pyriformis (Yoshioka et al. 1986). These authors also reported that 
251 mg/L concentration was lethal to 50% of the test organisms (LC50), killifish, Oryzias 
latipes (Yoshioka et al. 1986). Effluent tris(2-chloroethyl) phosphate concentrations of 
<0.1 µg/L, measured in this study, are significantly lower than the EC50 and LC50 values 
reported by Yoshioka et al. (1986) and are not likely to cause negative effects on aquatic 
life.  
Due to the high log Kow value and low solubility, high concentrations of bis(2-
ethylhexyl) phthalate are not likely to be found in aquatic environments in dissolved form. 
Wilson et al. (1978) reported a single 96-hour EC50 value of 31,000 mg/L for alga 
Gymnodinium breve. The high EC50 value implies low acute toxicity of bis(2-ethylhexyl) 
phthalate. The LC50 values, following a 96-hour exposure, for the copepod Nitocra 
spinipes and the mysid shrimp Mysidopsis bahia were stated to be >0.37 mg/L and >300 
mg/L respectively (Linden et al. 1979; Adams et al. 1995). These concentrations are by 
several orders of magnitude higher than the effluent concentration of bis(2-ethylhexyl) 
phthalate  detected in the presented study (<LOQ=<1.18 µg/L).  
Available toxicity data of the six PPCPs suggest that the concentrations of the 
compounds detected in the effluent of the three WWTPs are below the levels of concern 
reported in literature.  
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CONCLUSION 
The effectiveness of three wastewater treatment technologies represented by 
three WWTPs in Utah in removing ten PPCPs was evaluated. Influent, effluent and 
biosolids samples were collected in May, July, and August of 2011. Only six out of ten 
compounds were measured above the limit of quantitation in the wastewater influent of 
all three WWTPs. Physicochemical properties of these PPCPs were used to predict the 
fate of the compounds upon their entrance into WWTPs. In general, the predictions 
made using the log Kow/biodegradability data match the observed data.  The measured 
concentrations of the PPCPs were also compared to concentrations reported in 
literature. The influent concentrations of caffeine, acetaminophen, sulfamethoxazole, 
and tris(2-chloroethyl) phosphate were similar to those reported by other authors, with 
caffeine and acetaminophen being the most likely to be found. However, in this study, 
carbamazepine and bis(2-ethylhexyl) phthalate were observed at slightly lower 
concentrations in the influent than reported in the literature.  Effluent concentrations of all 
compounds were found to be consistent with reports by other authors, except for bis(2-
ethylhexyl) phthalate; its concentration in the effluent was <LOQ. The efficiencies of the 
three WWTPs in eliminating pharmaceuticals and personal care products were assessed 
by comparing the influent to the effluent concentrations. The results of Tukey’s test 
indicate that there is no statistical variation in removal efficiency between Brigham, 
Hyrum, and Spanish Fork wastewater treatment processes. Available toxicity data of the 
six PPCPs suggest that the concentrations of the compounds detected in the effluent of 
the three WWTPs are below the levels of concern reported in literature.  
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ENGINEERING SIGNIFICANCE 
The results of this study conducted on three WWTPs in the State of Utah, in 
addition to multiple studies carried out and published worldwide, continue to raise 
awareness of the anthropogenic presence of PPCPs in the environment. Although 
occurrence of PPCPs has been acknowledged and investigated for over a decade, it is 
still unclear whether their trace concentrations impose harmful effects on human health 
and environment. To our knowledge, to date there are no published data on occurrence 
and removal of PPCPs from WWTPs in Utah. The treatment processes chosen for this 
study are representative of the most common types of WWTPs in the State of Utah. 
Wastewater treatment technologies are not designed to treat for PPCPs, and their 
effluent concentrations are not regulated. The extent of elimination of PPCPs from 
wastewater influent depends not only on a wastewater treatment technology but also on 
physicochemical properties of a compound. It has been confirmed by this study that 
highly soluble compounds (low log Kow values) are more likely to leave a WWTP with the 
effluent. These compounds would be expected to enter natural waters. PPCPs with low 
solubility (high log Kow values) are more likely to leave a WWTP with biosolids, and 
therefore, potentially pose negative effects on terrestrial organisms.  
It was presented here that the removal performance of the Spanish Fork 
wastewater treatment technology is slightly superior to the other two treatment 
processes. However, according to Tukey’s test, there is no statistical difference between 
removal efficiencies by each of the three WWTPs. The elimination of PPCPs from 
wastewater influent is specific to wastewater matrix, wastewater treatment technology 
and physicochemical characteristics of PPCPs.  
This study assessed available toxicity data and compared it to the concentrations 
measured in the effluent of the three WWTPs in Utah. It was concluded that the effluent 
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concentrations from the three WWTPs are several orders of magnitude below the levels 
of concern of concentrations reported in literature and are not likely to pose negative 
effects on human health and the environment.  
The most common routes of human PPCPs into the environment are through 
excretion, bathing, and incorrect disposal of expired and unused medications. Drug 
collection programs and household hazardous waste programs have been established to 
reinforce proper disposal of such medications. These locations can be found at 
www.MedicationDisposal.utah.gov. However, if no collection options are available, the 
Utah Department of Environmental Quality recommends the following guidelines to 
properly dispose of expired and unused medications. First, they should be removed from 
their original containers and mixed with coffee grounds or kitty litter in an alternative 
sealable container. On the day of garbage pick-up the sealed container with medications 
should be disposed of in the trash (Utah DEQ and Lamb unknown).   
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APPENDIX A – Residuals’ check for normality based on the concentrations detected in 
the samples collected from three WWTPs in Utah in May, July, and August of 2011  
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APPENDIX B – Tukey’s test results for laboratory control spike recoveries  
> acid<-c(73,82,71,51,61,34,68,0,18,42) #1  
> base<-c(25,23,13,20,35,52,35,0,7,5) #2 
> neutral<-c(56,73,40,25,37,60,58,0,7,5) #3 
> data<-c(acid,base,neutral) 
> S<-rep(as.factor(c(1:3)),each=10) 
> M<-rep(as.factor(c(1:10)),times=3)  
> LCS<-data.frame(set=S,measurement=M,lcs=data) 
> LCS.aov<-aov(lcs~set+measurement,data=LCS) 
> summary(LCS.aov) 
            Df  Sum Sq Mean Sq F value    Pr(>F)     
set          2  4062.1 2031.03  9.8242 0.0013053 **  
measurement  9 10956.1 1217.35  5.8884 0.0007114 *** 
Residuals   18  3721.3  206.74                       
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1   
> TukeyHSD(LCS.aov,"set") 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
Fit: aov(formula = lcs ~ set + measurement, data = LCS) 
$set 
     diff        lwr        upr     p adj 
2-1 -28.5 -44.910907 -12.089093 0.0008939 
3-1 -13.9 -30.310907   2.510907 0.1054600 
3-2  14.6  -1.810907  31.010907 0.0861781 
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APPENDIX C – Tukey’s test results for removal efficiencies of the WWTPs   
> B1<-c(2.16,1.68,2.16,1.82,2.13,1.99) 
> H1<-c(2.16,1.90,2.14,0.75,2.02,1.95) 
> SF1<-c(2.16,2.15,2.12,2.04,2.14,2.05) 
> data<-c(B1,H1,SF1) 
> P<-rep(as.factor(c(1:3)),each=6) 
> M<-rep(as.factor(c(1:6)),times=3) 
> Removal<-data.frame(WWTP=P,measurement=M,rem=data)  
> Removal.aov<-aov(rem~WWTP+measurement,data=Removal)     
> summary(Removal.aov) 
            Df Sum Sq Mean Sq F value Pr(>F) 
WWTP         2 0.2548 0.12740  1.5480 0.2596 
measurement  5 0.8192 0.16384  1.9908 0.1657 
Residuals   10 0.8230 0.08230                
> TukeyHSD(Removal.aov,"WWTP") 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
 
Fit: aov(formula = rem ~ WWTP + measurement, data = Removal) 
$WWTP 
     diff       lwr      upr     p adj 
2-1 -0.17 -0.624041 0.284041 0.5779605 
3-1  0.12 -0.334041 0.574041 0.7550353 
3-2  0.29 -0.164041 0.744041 0.2348192 
 
> B2<-c(2.66,2.58,2.66,2.34,2.64,2.53) 
> H2<-c(2.66,2.6,2.66,2.32,2.42,2.54) 
> SF2<-c(2.66,2.59,2.65,2.52,2.65,2.58) 
> data<-c(B2,H2,SF2) 
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> P<-rep(as.factor(c(1:3)),each=6) 
> M<-rep(as.factor(c(1:6)),times=3) 
> Removal<-data.frame(WWTP=P,measurement=M,rem=data)  
> Removal.aov<-aov(rem~WWTP+measurement,data=Removal)     
> summary(Removal.aov) 
            Df   Sum Sq   Mean Sq F value   Pr(>F)    
WWTP         2 0.016900 0.0084500  1.9728 0.189594    
measurement  5 0.142867 0.0285733  6.6708 0.005564 ** 
Residuals   10 0.042833 0.0042833                     
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  
> TukeyHSD(Removal.aov,"WWTP") 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
Fit: aov(formula = rem ~ WWTP + measurement, data = Removal) 
$WWTP 
      diff         lwr        upr     p adj 
2-1 -0.035 -0.13858243 0.06858243 0.6369129 
3-1  0.040 -0.06358243 0.14358243 0.5592426 
3-2  0.075 -0.02858243 0.17858243 0.1663425 
> B3<-c(2.83,2.76,2.83,0.95,2.82,2.69) 
> H3<-c(2.83,2.76,2.83,2.78,2.81,2.78) 
> SF3<-c(2.83,2.76,2.81,2.68,2.82,2.72) 
> data<-c(B3,H3,SF3) 
> P<-rep(as.factor(c(1:3)),each=6) 
> M<-rep(as.factor(c(1:6)),times=3) 
> Removal<-data.frame(WWTP=P,measurement=M,rem=data)  
> Removal.aov<-aov(rem~WWTP+measurement,data=Removal)     
> summary(Removal.aov) 
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            Df  Sum Sq Mean Sq F value Pr(>F) 
WWTP         2 0.37248 0.18624  1.0646 0.3809 
measurement  5 1.09736 0.21947  1.2546 0.3543 
Residuals   10 1.74932 0.17493                
> TukeyHSD(Removal.aov,"WWTP") 
  Tukey multiple comparisons of means 
    95% family-wise confidence level 
Fit: aov(formula = rem ~ WWTP + measurement, data = Removal) 
$WWTP 
           diff        lwr       upr     p adj 
2-1  0.31833333 -0.3436241 0.9802908 0.4174057 
3-1  0.29000000 -0.3719574 0.9519574 0.4791162 
3-2 -0.02833333 -0.6902908 0.6336241 0.9924444 
 
 
 
 
